Replies to post #164112 on Cytodyn Inc (CYDY)

[DonDonDonDon]

I have been a shareholder since 2012.

Holy Toledo Batman

[misiu143]

Combo phase 3 pivotal study started in 2015 ,

ROT was never an issue or a problem.

Study in HIV combo finished with leronlimab , with 81% efficacy , with 350 mg , not one serious side effect , February 2018...

About June 2019 Dr Patterson developed ROT for Leronlimab , but study for combo were finished more then one year before ..

FDA asked them to start to do ROT on some mono patients..I am sure that Dr Patterson remember...

And only almost 3 years after combo was done , October 2020 , FDA asked for ROT for BLA for combo , but not only from combo but for ALL over 500 patients in MONO...

WHY ??

IMO only...